Loading…

Persistence of IgG4 as a potential serological marker of disease activity in patients with epidermolysis bullosa acquisita treated with rituximab

Saved in:

Bibliographic Details
Published in:	Journal of the European Academy of Dermatology and Venereology 2024-01, Vol.38 (1), p.e45-e47
Main Authors:	Gordilho, J. O., Miyamoto, D., Maruta, C. W., Santo, R. M., Mahmoud, A., Navarro‐Rodriguez, T., Werneck‐Silva, A. L., Aguiar, L. M., Borges, I. C., Santi, C. G., Aoki, V.
Format:	Article
Language:	English
Subjects:	Epidermolysis Bullosa Epidermolysis Bullosa Acquisita - diagnosis Epidermolysis Bullosa Acquisita - drug therapy Humans Immunoglobulin G - blood Rituximab - therapeutic use
Citations:	Items that this one cites
Online Access:	Get full text
Tags:	Add Tag No Tags, Be the first to tag this record!